ArticleFrontiers in pharmacology2023

Safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of aficamten in healthy Chinese participants: a randomized, double-blind, placebo-controlled, phase 1 study.

Xue Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.